RemeGen Co (SHSE:688331) 3-Year Revenue Growth Rate : 0.00% (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is RemeGen Co 3-Year Revenue Growth Rate?

RemeGen Co's Revenue per Share for the six months ended in Jun. 2024 was ¥1.37.

During the past 12 months, RemeGen Co's average Revenue per Share Growth Rate was 65.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 6 years, the highest 3-Year average Revenue per Share Growth Rate of RemeGen Co was 409.80% per year. The lowest was 409.80% per year. And the median was 409.80% per year.

Competitive Comparison of RemeGen Co's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, RemeGen Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RemeGen Co's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, RemeGen Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where RemeGen Co's 3-Year Revenue Growth Rate falls into.

RemeGen Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

RemeGen Co (SHSE:688331) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

RemeGen Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of RemeGen Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

RemeGen Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RemeGen Co Ltd (SHSE:688331) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

REGMF:USA 09995:Hong Kong REG:Germany

Address

58 Middle Beijing Road, Yantai Area of Shandong Pilot Free Trade Zone, Yantai Development Zone, Yantai, CHN

Website

https://www.remegen.com

RemeGen Co Ltd is a China-based company mainly engaged in the research, development and manufacture of innovative biopharmaceuticals. The company offers Telitacicept (RC18) for use in the treatment of systemic lupus erythematosus an autoimmune disease and Disitamab Vedotin (RC48) for use in the treatment of various cancers. The company's products are mainly used to treat major diseases such as autoimmune diseases, oncology, and ophthalmology. The company has its operations in China and the USA and derives the majority of its revenue from China.

RemeGen Co Headlines

No Headlines